Mark J Kupersmith1, Patrick A Sibony2, Steven E Feldon3, Jui-Kai Wang4, Mona Garvin4, Randy Kardon5. 1. Mount Sinai West Hospital, New York, New York; New York Eye and Ear Infirmary and Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: mkuper@chpnet.org. 2. Department of Ophthalmology, State University of New York at Stony Brook, Stony Brook, New York. 3. Department of Ophthalmology, University of Rochester School of Medicine & Dentistry, Rochester, New York. 4. Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa. 5. Department of Ophthalmology and Vision Sciences, Iowa City VA Health Care System, Iowa City, Iowa.
Abstract
PURPOSE: We described 3 types of folds in the retina and a crease in the outer retina associated with papilledema owing to idiopathic intracranial hypertension (IIH) at presentation. We report the change in folds relative to treatment of IIH over the 6 months. METHODS: In this substudy of a randomized clinical trial, study eyes of subjects assigned to acetazolamide (ACZ, n = 44) or placebo (PLB, n = 43) had spectral-domain optical coherence tomography (SDOCT) images of the optic disc and macula regions at baseline and at 3 and 6 months. Images were evaluated for peripapillary wrinkles (PPW), retinal folds (RF), choroidal folds (CF), and creases using transaxial and en face views. The optic nerve head (ONH) shape, retinal nerve fiber layer (RNFL) thickness, ONH volume, and papilledema grade were measured. Outcome was determination of the presence or absence of PPW, RF, CF, and creases. RESULTS: At presentation, except for an increase of PPW in ACZ eyes (64% vs 28%), both treatment groups were matched for all OCT features. At 6 months, ACZ-treated, but not PLB-treated, eyes had fewer folds of all types (P < .01), with a 57% reduction in frequency of RF. Creases did not resolve. Resolution of RF, but not of PPW and CF, was associated with significant reduction in RNFL thickness, ONH volume, and papilledema grade. CONCLUSIONS: The various types of retinal folds associated with papilledema reflect biodynamic processes and show an ACZ treatment effect. Persistence of these folds despite marked improvement in ONH swelling suggests permanent changes in the affected retinal tissues.
RCT Entities:
PURPOSE: We described 3 types of folds in the retina and a crease in the outer retina associated with papilledema owing to idiopathic intracranial hypertension (IIH) at presentation. We report the change in folds relative to treatment of IIH over the 6 months. METHODS: In this substudy of a randomized clinical trial, study eyes of subjects assigned to acetazolamide (ACZ, n = 44) or placebo (PLB, n = 43) had spectral-domain optical coherence tomography (SDOCT) images of the optic disc and macula regions at baseline and at 3 and 6 months. Images were evaluated for peripapillary wrinkles (PPW), retinal folds (RF), choroidal folds (CF), and creases using transaxial and en face views. The optic nerve head (ONH) shape, retinal nerve fiber layer (RNFL) thickness, ONH volume, and papilledema grade were measured. Outcome was determination of the presence or absence of PPW, RF, CF, and creases. RESULTS: At presentation, except for an increase of PPW in ACZ eyes (64% vs 28%), both treatment groups were matched for all OCT features. At 6 months, ACZ-treated, but not PLB-treated, eyes had fewer folds of all types (P < .01), with a 57% reduction in frequency of RF. Creases did not resolve. Resolution of RF, but not of PPW and CF, was associated with significant reduction in RNFL thickness, ONH volume, and papilledema grade. CONCLUSIONS: The various types of retinal folds associated with papilledema reflect biodynamic processes and show an ACZ treatment effect. Persistence of these folds despite marked improvement in ONH swelling suggests permanent changes in the affected retinal tissues.
Authors: W H Morgan; D Y Yu; V A Alder; S J Cringle; R L Cooper; P H House; I J Constable Journal: Invest Ophthalmol Vis Sci Date: 1998-07 Impact factor: 4.799
Authors: Michael Wall; Michael P McDermott; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Mark J Kupersmith Journal: JAMA Date: 2014 Apr 23-30 Impact factor: 56.272
Authors: Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302
Authors: Patrick Sibony; Mark J Kupersmith; Robert Honkanen; F James Rohlf; Ali Torab-Parhiz Journal: Invest Ophthalmol Vis Sci Date: 2014-11-18 Impact factor: 4.799
Authors: Mohammad Shafkat Islam; Jui-Kai Wang; Samuel S Johnson; Matthew J Thurtell; Randy H Kardon; Mona K Garvin Journal: Transl Vis Sci Technol Date: 2020-03-24 Impact factor: 3.283
Authors: Leonardo E Ariello; Luiz Guilherme Marchesi Mello; Sérgio Luis Gianotti Pimentel; Mário L R Monteiro Journal: Int J Retina Vitreous Date: 2022-07-22